Molecularly imprinted polymers for the recognition of biomarkers of certain neurodegenerative diseases - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Journal of Pharmaceutical and Biomedical Analysis Année : 2023

Molecularly imprinted polymers for the recognition of biomarkers of certain neurodegenerative diseases

Mikhael Bechelany

Résumé

The appearance of the biomarkers in body fluids like blood, urine, saliva, tears, etc. can be used for the identification of many diseases. This article aimed to summarize the studies about electrochemical biosensors with molecularly imprinted polymers as sensitive and selective layers on the electrode to detect protein-based biomarkers of such neurodegenerative diseases as Alzheimer's disease, Parkinson's disease, and stress. The main attention in this article is focused on the detection methods of amyloid-β oligomers and p-Tau which are representative biomarkers for Alzheimer's disease, α-synuclein as the biomarker of Parkinson's disease, and α-amylase and lysozyme as the biomarkers of stress using molecular imprinting technology. The research methods, the application of different electrodes, the influence of the polymers, and the established detection limits are reviewed and compared
Fichier principal
Vignette du fichier
Mini Review on MIP-disease markers_v10-AR.pdf (270.47 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04051040 , version 1 (14-10-2023)

Identifiants

Citer

Greta Pilvenyte, Vilma Ratautaite, Raimonda Boguzaite, Urte Samukaite-Bubniene, Deivis Plausinaitis, et al.. Molecularly imprinted polymers for the recognition of biomarkers of certain neurodegenerative diseases. Journal of Pharmaceutical and Biomedical Analysis, 2023, 228, pp.115343. ⟨10.1016/j.jpba.2023.115343⟩. ⟨hal-04051040⟩
24 Consultations
24 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More